Description
Lampit (nifurtimox) is used to treat Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi, in patients from birth to less than 18 years old who weigh 2.5 kg or more.
Fact Table |
Formula |
C10H13N3O5S |
License |
US DailyMed |
Bioavailability |
Low |
Legal status |
Rx-only |
Chemical Name |
Nifurtimox |
Elimination half-life |
2.95 ± 1.19 hours |
Dosage (Strength) |
30mg, 60mg |
Pregnancy |
Not recommended |
Brands |
Vermox |
Protein binding |
42% |
PubChem CID |
6842999 |
MedlinePlus |
a620061 |
ChEBI |
7566 |
ATC code |
P01CC01 |
DrugBank |
DB11820 |
KEGG |
D00833 |
Routes of administration |
By mouth |
Directions
The instructions on the prescription should be followed. Talk to your doctor or pharmacist about any questions or concerns you may have.
Lampit is available in 30 mg and 120 mg tablets that are scored.
Dosing:
Patients who weigh at least 41 kg: 8-10 mg/kg total per day.
Patients who weigh less than 41 kg: 10 to 20 mg/kg total per day.
Lampit should be taken by mouth three times a day with food for 60 days.
A pregnancy test should be taken in women who are of childbearing age before starting treatment with Lampit.
Ingredients
The active ingredient in Lampit is nifurtimox, a nitrofuran antiprotozoal.
Contraindications
Lampit should not be taken in patients who are allergic to nifurtimox or any of its other ingredients or excipients.
Patients should not consume alcohol during treatment with Lampit.
Cautions
- Before starting treatment with Lampit, patients should tell their doctor:
- About all the medications they take, including prescription and over-the-counter, vitamins, and herbal supplements
- About their allergies
- About their health conditions
- If they are pregnant or plan to become pregnant
- If they are breastfeeding or plan to breastfeed
- Genotoxicity and carcinogenicity may potentially occur with the use of Lampit.
- Lampit may cause harm to an unborn baby. A pregnancy test should be taken in women of childbearing age before starting treatment with Lampit. Birth control methods should be used. Males should use condoms.
- Lampit may worsen neurological and psychiatric conditions, especially in patients who have or have had a brain injury, seizures, psychiatric disease, and serious behavioral changes.
- Lampit may cause severe allergic reactions such as low blood pressure, swelling under the skin, shortness of breath, itching, rash, or other skin reactions. Patients should seek medical care right away if any of these occur.
- Lampit may cause a decrease in appetite and weight. Patients should monitor their weight every 2 weeks. The dose may be adjusted based on weight.
- Lampit may cause porphyria, which is an excess of chemicals in the body that make porphyrin.
Side Effects
The side effects caused by Lampit include, but are not limited to, stomach pain, nausea, vomiting, headache, decreased appetite, fever, and rash. Call your doctor right away if you develop side effects that bother you or won't go away.
References:
- Lampit (nifurtimox) tablets, for oral use. Whippany, NJ: Bayer HealthCare Pharmaceuticals Inc.; 2020.
- Porphyria. Mayo Clinic. June 3, 2020. Accessed March 22, 2022.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13653